Search

Product descriptionRectal suspension Salofalk is indicated for the treatment of exacerbations of ulcerative colitis.CompoundActive substance: mesalazine;1 enema (60 g of suspension) contains 4.0 g of mesalazine (5-aminosalicylic acid);Excipients: sodium benzoate (E 211), potassium metabisulfite (E 2..

Product descriptionSalofalk gastro-resistant granules of prolonged action are indicated for the treatment of exacerbations and the prevention of recurrence of ulcerative colitis.CompoundActive substance: mesalazine;1 sachet (930 mg of granules) contains mesalazine 500 mg or 1 sachet (1860 mg of gran..

Product descriptionSalofalk gastro-resistant granules of prolonged action are indicated for the treatment of exacerbations and the prevention of recurrence of ulcerative colitis.CompoundActive substance: mesalazine;1 sachet (930 mg of granules) contains mesalazine 500 mg or 1 sachet (1860 mg of gran..

Product descriptionRectal suppositories (suppositories) Salofalk are indicated for the treatment of exacerbations and the prevention of recurrence of ulcerative colitis limited to the rectum.CompoundActive substance: mesalazine;1 suppository contains 250 mg of mesalazine (5-aminosalicylic acid);Exci..

Product descriptionRectal suppositories "Salofalk" are used to treat exacerbations and prevent recurrence of ulcerative colitis limited to the rectum.CompoundThe active ingredient is mesalazine (1 suppository contains 250 mg of mesalazine (5-aminosalicylic acid)).The excipient is solid fat.Contraind..

Product descriptionRectal suppositories (suppositories) Salofalk are indicated for the treatment of exacerbations and the prevention of recurrence of ulcerative colitis limited to the rectum.CompoundActive substance: mesalazine;1 suppository contains 1000 mg of mesalazine (5-aminosalicylic acid);Exc..

Product descriptionSalofalk gastro-resistant granules of prolonged action are indicated for the treatment of exacerbations and the prevention of recurrence of ulcerative colitis.CompoundActive ingredient: mesalazine (5-aminosalicylic acid);1 bag (2.79 g of granules) contains mesalazine 1.5 g or 1 ba..

Product descriptionSalofalk gastro-resistant granules of prolonged action are indicated for the treatment of exacerbations and the prevention of recurrence of ulcerative colitis.CompoundActive ingredient: mesalazine (5-aminosalicylic acid);1 bag (2.79 g of granules) contains mesalazine 1.5 g or 1 ba..